![Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S. | Markets Insider Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S. | Markets Insider](https://mma.prnewswire.com/media/609394/Boehringer_Ingelheim_Pharmaceuticals_Inc___Logo.jpg)
Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S. | Markets Insider
Boehringer Ingelheim on LinkedIn: New cancer therapeutics collaboration with 3T Bio | Boehringer Ingelheim
![Deaths Lead Boehringer Ingelheim to Cancel $730 Million Cancer Deal With Hanmi Pharma, Hanmi Stock Tanks | BioSpace Deaths Lead Boehringer Ingelheim to Cancel $730 Million Cancer Deal With Hanmi Pharma, Hanmi Stock Tanks | BioSpace](http://enewsletters.biospace.com/images/news/biospace-news-815x450-boehringer-ingelheim.jpg)
Deaths Lead Boehringer Ingelheim to Cancel $730 Million Cancer Deal With Hanmi Pharma, Hanmi Stock Tanks | BioSpace
![China. 19th Feb, 2023. In this photo illustration, the German research-driven pharmaceutical company, Boehringer Ingelheim logo is seen displayed on a smartphone with an economic stock exchange index graph in the background. China. 19th Feb, 2023. In this photo illustration, the German research-driven pharmaceutical company, Boehringer Ingelheim logo is seen displayed on a smartphone with an economic stock exchange index graph in the background.](https://c8.alamy.com/comp/2NYD50C/china-19th-feb-2023-in-this-photo-illustration-the-german-research-driven-pharmaceutical-company-boehringer-ingelheim-logo-is-seen-displayed-on-a-smartphone-with-an-economic-stock-exchange-index-graph-in-the-background-credit-sopa-images-limitedalamy-live-news-2NYD50C.jpg)